Novo Nordisk A/S   Novo Nordisk Biotech Fund Novo Nordisk Biotech Fund
 
Search
 Search
Send to a friendPrint

News archive


15 September 2009
Pieris AG enters into Anticalin collaboration with Allergan, Inc.
Read more

15 September 2009
Affimed Therapeutics AG receives FDA Orphan Drug Designation for AFM13 against Hodgkin lymphoma
Read more

15 April 2009
Osprey Pharmaceuticals USA initiates Phase Ib Clinical Trial.
Read more

8 January 2009
Osprey Pharmaceuticals USA receives CTA approval from Health Canada for its lead compound
Read more

17 December 2008
Novo Nordisk Biotech Fund invests in VLST Corporation
Read more

15 September 2008
Osprey Pharmacuticals USA, Inc. featured in Fierce Biotech
Read more

3 September 2008
Novo Nordisk Biotech Fund invests in Osprey Pharmacuticals USA, Inc.
Read more

27 March 2008
Novo Nordisk Biotech Fund invests in Pieris AG
Read more
 
20 February 2008  
Novo Nordisk Biotech Fund invests EUR 5 million in Affimed Therapeutics AG
Read more

27 June 2007
Apoxis SA acquired by the Danish biotech company TopoTarget A/S
Read more

8 December 2006   
GSK to acquire Domantis in a GBP 230 million cash deal
Read more

24 October 2006    
Novo Nordisk Biotech Fund invests USD 9 million in Xencor
Read more